Inclusio SA
F:9ZS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inclusio SA
F:9ZS
|
BE |
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
|
O
|
OpGen Inc
F:6502
|
US |
|
Maha Properti Indonesia Tbk PT
IDX:MPRO
|
ID |
|
S
|
Swatch Group AG
DUS:UHR
|
CH |
Wall St Price Targets
9ZS Price Targets Summary
Inclusio SA
According to Wall Street analysts, the average 1-year price target for 9ZS is 20.91 EUR with a low forecast of 20.2 EUR and a high forecast of 22.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9ZS's stock price target?
Price Target
20.91
EUR
According to Wall Street analysts, the average 1-year price target for 9ZS is 20.91 EUR with a low forecast of 20.2 EUR and a high forecast of 22.05 EUR.
What is the Revenue forecast for Inclusio SA?
Projected CAGR
9%
Over the last 7 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Inclusio SA?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 124%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Inclusio SA?
Projected CAGR
-15%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 74%. The projected CAGR for the next 3 years is -15%.
What is the Net Income forecast for Inclusio SA?
Projected CAGR
-15%
Over the last 7 years, the compound annual growth rate for Net Income has been 75%. The projected CAGR for the next 3 years is -15%.
